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Abstract: We estimate the weekly excess all-cause mortality in Norway and Sweden, the years of
life lost (YLL) attributed to COVID-19 in Sweden, and the significance of mortality displacement.
We computed the expected mortality by taking into account the declining trend and the seasonality
in mortality in the two countries over the past 20 years. From the excess mortality in Sweden in
2019/20, we estimated the YLL attributed to COVID-19 using the life expectancy in different age
groups. We adjusted this estimate for possible displacement using an auto-regressive model for
the year-to-year variations in excess mortality. We found that excess all-cause mortality over the
epidemic year, July 2019 to July 2020, was 517 (95%CI = (12, 1074)) in Norway and 4329 [3331, 5325] in
Sweden. There were 255 COVID-19 related deaths reported in Norway, and 5741 in Sweden, that year.
During the epidemic period of 11 March–11 November, there were 6247 reported COVID-19 deaths
and 5517 (4701, 6330) excess deaths in Sweden. We estimated that the number of YLL attributed
to COVID-19 in Sweden was 45,850 [13,915, 80,276] without adjusting for mortality displacement
and 43,073 (12,160, 85,451) after adjusting for the displacement accounted for by the auto-regressive
model. In conclusion, we find good agreement between officially recorded COVID-19 related deaths
and all-cause excess deaths in both countries during the first epidemic wave and no significant
mortality displacement that can explain those deaths.
Keywords: COVID-19; years of life lost; excess mortality; mortality displacement
1. Introduction
There is an ongoing scientific and public debate worldwide about the optimal strategy
for mitigating the negative impacts of the COVID-19 pandemic [1–6]. In Europe, most
countries executed strong non-pharmaceutical interventions in March 2020 to combat the
disease’s explosive spread and, by early summer, the epidemic was reasonably controlled.
Among the western European countries, Sweden was an exception, adopting a strategy
of implementing mainly voluntary measures [7]. As a consequence, the rate of confirmed
cases entered a second and more substantial wave in June and a third and even stronger
one throughout the autumn, coinciding with the widespread second wave in Europe. In
Europe, the COVID-19-specific mortality rate saw one broad wave lasting from March
until July, then a calm period from August until October when a second wave started.
The confirmed cumulative COVID-19 death toll in Sweden until 11 November was 6247,
which corresponds to 611 deaths per million [8]. This figure is typical for Europe but high
compared to Sweden’s Nordic neighboring countries. In particular, Norway, which is very
similar to Sweden in terms of culture, demographic development, and social policies [9,10],
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has chosen a much more strict approach against COVID-19. As a result, by 11 November,
Norway had only 285 confirmed deaths (53 per million) related to COVID-19 [8].
It has been suggested that the criticism of the Swedish strategy has been based on the
perception that death from coronavirus infection somehow is more harmful to society than
death from another infection [11]. The implicit assumption behind this suggestion is that
the pandemic’s mortality rate was not substantially higher than during previous seasonal
influenzas and that all-cause excess mortality in Sweden differed significantly from the
confirmed coronavirus-related mortality throughout the pandemic wave. In this paper, we
investigate the validity of these assumptions. We also estimate the years of life lost (YYL)
in Sweden that can be attributed to its relaxed mitigation strategy.
A standard method for estimating excess mortality is to compute how the number of
weekly or monthly deaths in 2020/21 differs as a percentage from the average number of
deaths in the same period over the years 2015–2019. This metric is called the P-score, and
takes the form of a time series with weekly or monthly resolution. According to Our World
in Data [12], it peaked at 9 percent on 29 March in Norway, and at 47 percent in Sweden
on 12 April 2020. An overview of the excess mortality computed this way for Germany,
Italy, Norway, Sweden, and Switzerland during the first wave of the COVID-19 pandemic
is given in an EFTA publication dated 16 December 2020 [13].
There are two obvious caveats of this method. One is that mortality from the seasonal
influenza varies considerably from year to year, and hence it is not given that the average
of the deaths in the same week over the previous five years is a good estimate of the
expected mortality for that time of the year. Another is that mortality exhibits a long-term
negative trend. Not taking that trend into account leads to an underestimation of the excess
mortality during the pandemic. The long-term trend is taken into account in the Z-score
employed in the EuroMoMo model [14] but, as explained in Section 2.3, the seasonal trend
is not fully accounted for.
Section 2 presents simple methods for estimating the years of life lost (YLL) and the
expected (or baseline) signal for mortality including the long term trend and the seasonal
variation based on 20 years of data. This allows us to estimate a more reliable excess
mortality during the first pandemic wave and the preceding years. We employ all-cause
mortality data up to the end of the first wave, but not for the second wave. The reason for
this is that the second wave in most European countries initially was transmitted mainly in
the younger age groups, in contrast to the first wave that spread quickly in the older part
of the population. Mitigation policies were also considerably more similar in Norway and
Sweden during the fall and early winter of 2020/21. Therefore, there is ample reason to
believe that an analysis of excess mortality for the second and later waves will give different
results from what we present here. This is one of the reasons why Vaclav Smil suggests
that it is too early to judge Sweden’s COVID-19 policy [15]. Nevertheless, conclusions
cannot be drawn if there remains significant doubt about the actual contribution of the
first pandemic wave to the excess mortality and to the years of life lost in the neighboring
countries, Norway and Sweden.
2. Materials and Methods
2.1. Data Sources
Weekly mortality data in Sweden and Norway for the last 20 years were downloaded
from Statistics Sweden (SCB) [16] and Statistics Norway (SSB) [17]. The proportion of
deaths in 2020 in Sweden by age group and the life expectancy by age group were also
obtained from SCB and are reported in Table 1. Data for COVID-19-related deaths were
obtained from ourworldindata.org [8].
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Table 1. Proportion of deaths in 2020 in Sweden by age group and life expectancy by age group. Data
source: Statistics Sweden (SCB).
Age Group (yrs) Proportion of 2020 Deaths Life Expectancy (yrs) Estimate (SD)
50–64 10% 27.5 (3.8)
65–79 30% 15.6 (3.3)
80–89 35% 7.0 (1.6)
>90 25% 2.5 (0.9)
2.2. Estimates of Years of Life Lost
Using data on life expectancy in different age groups in Sweden [16] (Table 1) we
simulated the YLL using the model:
YLL = X[0.10r1 + 0.30r2 + 0.35r3 + 0.25r4], (1)
where the random variable X represents excess mortality, with the estimated distribution
for 2019/2020, and the random variables r1, . . . , r4 represent the life expectancies of each
age group from Table 1. We assumed the life expectancies to be independent and normally
distributed random variables. From the reported statistics on life expectancy, the resulting
estimate is YLL = 45,850 (13,915, 80,276).
2.3. Estimate of Expected Mortality-Rate Signal
The mortality rate in Scandinavia has a seasonal variation and is higher in the boreal
winter [18]. As shown in Figure 1A, the weekly number of all-cause deaths also shows a
significant negative linear trend (p = 10−15 for Norway and p = 10−7 for Sweden) over
the last 20 years.
The expected mortality-rate signal is computed from the average seasonality and the
linear trend. We first computed the linear trend in the mortality time series by means of
simple linear regression. After subtracting the trend, we computed the expected seasonal
variation over a year by averaging the number of deaths in the epidemic year (i.e., the
time series that goes from July to July of next year) over those 20 years. By repeating this
expected seasonal variation over the 20 years and by adding the linear trend, we obtained
the expected mortality-rate time series.
In the following, we will refer to such an expected mortality-rate signal as the baseline
signal. Our definition of the baseline is different from that employed in computing the Z-
score adopted by the widely used EuroMoMo model [14]. Their seasonal baseline function
looks like a sinusoidal function, which does not include the peak of an expected winter
influenza. This implies that this expected peak will be recorded as excess deaths. The
Z-score is reasonable when the seasonal influenza is the main object of study, but not when
this object is a pandemic like COVID-19, where the point is to distinguish the pandemic
deaths from those attributed to the seasonal influenza.
2.4. Estimate of Excess Mortality Rate
The excess mortality rate for a given week is the weekly mortality rate that week
minus the baseline at the time. It can be positive or negative, depending on whether the
instantaneous mortality rate that week is above or below the baseline.
The excess mortality is a random process where the value for a given week is given in
terms of an estimate for the expected value and a 95% confidence interval (CI). The CI for
the estimate of the excess mortality-rate was computed using a Monte–Carlo simulation
in which we repeatedly randomized the estimated excess mortality-rate signal without
changing its correlation structure. This was achieved by first performing a Fourier trans-
form, then randomizing the phases of the Fourier coefficients, and finally inverting the
transform [19]. We added this new realization of the excess mortality random process to
the previously estimated expected mortality signal. Finally, we made new estimates of the
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trend and seasonal variation to obtain new realizations of the expected mortality signal.
After this procedure, we obtained a distribution from which we could compute the mean
and a CI of the excess mortality rate.
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Figure 1. Expected and observed mortality. (A) The weekly deaths in Norway and Sweden (red)
together with the estimated baseline (black). (B) Same as for Norway in (A), but for the years 2016/17
to 2020/21. The gray region shows the interquartile range for the seasonal variation. (C) As (B), but
for Sweden. (D) The excess weekly mortality in Norway (red) and COVD-19-related deaths (black).
The error bars is the 95% CI for the excess mortality based on the Monte–Carlo simulation for the
estimate of the baseline. (E) As (D), but for Sweden.
2.5. Estimate of Mortality Displacement
Year-to-year variations of all-cause mortality are dominated by variations in seasonal
influenza, and we should observe negative correlations between excesses in a given year
and the following year (or years). In other words, we should observe this negative correla-
tion in the auto-correlation function (ACF) for the weekly all-cause excess time series. We
computed the ACF based on 20 years of weekly excess mortality rate data for Norway and







(xt − xt+τ) (2)
where τ is the time lag, µ is the sample mean and σ2 the sample variance of the weekly
excess mortality rate signal of length N = 1040 weeks. We estimate the ACF from the
annual data, while the error bars are computed by estimating the ACF for 52 different
signals with annual resolution. We had 52 samples since there are 52 weeks in a year.
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The effect of mortality displacement on excess mortality and YLL is studied by model-
ing the annual excess mortality as a first-order autoregressive (AR1) process. The justifica-
tion of this modeling choice is based on the estimated ACF, which indicates the presence
of very short memory in the excess mortality process. This is reasonable, since we expect
oscillations in all-cause mortality to be compensated quickly in the following year(s). The
AR1 models the annual excess mortality Xt as:
Xt+∆t = φXt + ξt (3)
where ∆t = 1 yr and ξt is a white-noise term.
To find the parameter φ in Equation (3) we used the standard maximum-likelihood
estimator. The maximum likelihood estimator is known to be biased for a short time series
but for small negative values of φ, such a bias is negligible [20]. To estimate a distribution
for φ, we use a bootstrapping method where we simulated the estimated process and
re-estimated the parameter φ repeatedly. From such a distribution we extract the mean
value and a 95% CI.
3. Results
3.1. The Expected and Excess Mortality Rate
Figure 1A shows the expected (black line) and recorded (red line) all-cause mortality
in Norway and Sweden over the last 20 years with weekly resolution. In Figure 1B,C
we plot the expected all-cause mortality rate for Norway and Sweden over the epidemic
seasons from 2016/17 up to 2020/21 and the recorded rate up to 11 November 2020.
For both countries, mortality during the winters of 2016/17 and 2017/18 was higher
than the baseline, mostly because of stronger-than-normal seasonal influenza [21]. In
Sweden, the mortality rate in 2018/19 and 2019/20 was below the baseline until the
COVID-19 outbreak in March 2020. Still, after 11 March, it was way above until July and
then remained slightly below until November. We estimated the excess mortality rate
during the epidemic from 11 March until 11 November as the difference between the
observed and expected rate. We compared it to the numbers of weekly reported COVID-19
deaths (Figure 1D,E). The excess all-cause deaths were slightly more numerous than the
reported COVID-19 deaths in both countries during the peak of the first epidemic wave.
3.2. Excess Mortality and Mortality Displacement
In Figure 2A,B we plot the excess mortality rate over the last four years. The blue lines
mark the mean excess rate for each epidemic year (from July until July next year).
For both countries, we observe that the two first years are above baseline. For Norway,
the year preceding the pandemic was at the baseline, while during the pandemic year
2019/20, the death number was 517 (−12, 1074), where the numbers in the brackets
represent the 95% confidence interval. In Sweden, the pre-pandemic year saw −1596
(−2508, −680) deaths (below baseline), while the pandemic year had an excess number of
4329 (3331, 5325). The 255 reported COVID-19 deaths in Norway is within the confidence
interval for the excess estimates, and the 5741 in Sweden is slightly above. For the epidemic
period 11 March–11 November, however, Sweden had 6247 reported COVID-19 deaths
which is within the confidence interval of the 5517 (4701, 6330) excess deaths for this period.
Using the same definition, we estimated the annual excess numbers for the last 20 epidemic
years (Table 2 and Figure 2C,D).
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Figure 2. Excess mortality. (A) Weekly excess mortality for Norway from 2016/17 and through the
first months of the epidemic year 2020/21. The blue lines are the average values for each of the
five epidemic years. (B) As (A), but for Sweden. (C) The annual excess mortality for Norway from
2000/01 to 2019/20. The error bars are the 95% confidence intervals. (D) As (C), but for Sweden.
Table 2. Excess mortality per (epidemic) year. The excess mortality is defined as the registered deaths
per year minus the expected number of deaths. The expected number of deaths are obtained from a
model with a linear trend superposed on a seasonal signal. The confidence intervals are obtained
by repeated re-estimates of the linear trend and seasonal signal in a Monte–Carlo simulation. The
asterisk in the last row indicates that epidemic year is not completed yet.
Year
Excess Mortality in Norway Excess Mortality in Sweden
Estimate (95% CI) Estimate (95% CI)
2000/01 334 (−180, 838) −825 (−1752, 84)
2001/02 866 (391, 1331) 587 (−261, 1410)
2002/03 621 (173, 1050) 1227 (466, 1946)
2003/04 −591 (−1002,−192) −1609 (−2281,−956)
2004/05 −977 (−1353,−606) 331 (−261, 903)
2005/06 −1874 (−2215,−1527) −2283 (−2803,−1790)
2006/07 59 (−254, 373) 758 (314, 1188)
2007/08 −371 (−661,−95) −67 (−449, 305)
2008/09 105 (−161, 367) 825 (497, 1151)
2009/10 −1043 (−1298,−783) −2197 (−2505,−1885)
2010/11 163 (−98, 435) 87 (−241, 422)
2011/12 633 (362, 933) 1443 (1073, 1825)
2012/13 456 (160, 777) 1718 (1281, 2156)
2013/14 −732 (−1048,−390) −1959 (−2467,−1448)
2014/15 608 (254, 980) 2131 (1547, 2717)
2015/16 −793 (−1178,−390) −1046 (−1707,−378)
2016/17 682 (258, 1111) 1811 (1069, 2564)
2017/18 731 (281, 1196) 1450 (623, 2283)
2018/19 −15 (−516, 495) −1596 (−2508,−680)
2019/20 517 (−12, 1074) 4329 (3331, 5325)
2020/21∗ 646 (362, 957) −1501 (−1917,−1079)
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From Figure 2B,D one can suspect that a negative excess death rate before the pan-
demic in Sweden has produced a pool of survivors that potentially could be particularly
vulnerable to COVID-19. But the existence of this pool does not imply that it actually
contributed more than normal to the COVID-19 deaths. If this displacement mechanism
really has played an important rôle in determining the fluctuations of the all-cause excess
mortality rate in Scandinavia, it should be observable in its time series and not only in the
two successive epidemic years 2018/19 and 2019/20. We explore this effect in Section 3.3.
3.3. The Tiny Effect of Mortality Displacement on Excess Deaths and YLL
It has been suggested that low mortality in years of low seasonal influenza will spill
over to the following year(s) and give rise to higher than normal mortality, and that this
effect explains a substantial part of the excess mortality during the COVID-19 first wave
in Sweden [9]. Figure 3 shows the estimated ACF for Norway and Sweden based on
20 years of weekly data (1040 data points). The confidence intervals for each year of time
lag are given as error bars in the figures. Only a very weak correlation can be detected on
time scales longer than the duration of the peak season for influenza. This suggests that
mortality displacement is not generally a major driver of excess mortality fluctuations in
Norway and Sweden.
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Figure 3. Auto-correlation function of the excess mortality signal. (A) The black curve shows the
autocorrelation function estimated from the weekly excess mortality in Norway. The dashed lines
indicate the 95% confidence interval under the assumption of uncorrelated data. The blue points
show the autocorrelation function estimated from yearly excess mortality, and the blue error bars
show the spread between the correlations estimated using different weeks of each year. (B) As in (A),
but for Sweden.
In Section 2.5, we described how to model the mortality time series as an AR1-process
and how to estimate the AR1 coefficient φ, which can be interpreted as the autocorrelation
between the excess mortality between two successive years. In Sweden, we observe a slight
anti-correlation in the year-to-year excess mortality given by the estimated AR1 coefficient
φ = −0.11 (−0.50, 0.30). Hence, it is conceivable that the large excess mortality in 2019/20
may cause a response of negative excess mortality in the coming years.
If X is the observed excess mortality in 2019/20, the anticorrelation would lead to a
negative excess mortality, φX, in 2020/21, a positive one, φ2X, in 2021/22, and so on. This
would lead to an adjustment of excess mortality during the first COVID-19 wave due to its
effect on the predicted mortality in the subsequent years. According to the AR1 model, the
adjusted mortality is:
Xadj = (1 + φ + φ2 . . .)X = ρX, (4)
where ρ = φ/(1 − φ).
The estimated mean of ρ is −0.06, the median is −0.10, and the 95% CI is (−0.33, 0.43).
Using the distribution of ρ to take the effect of possible displacement into account, the
excess mortality in Sweden for 2019/20 is adjusted to a mean value of 4098 (2706, 6421)
(Figure 4A). Carrying out the estimates of YLL with this distribution of excess mortality in
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2019/20 we obtained an YLL estimate of 43,073 (12,160, 85,451). Compared to the result in
Section 2.2, the mean is reduced by 6% (Figure 4B).
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Figure 4. Effect of mortality displacement. (A) The yellow histogram shows the estimated proba-
bility density function for excess deaths obtained from the Monte–Carlo simulation of the baseline.
The blue histogram is the excess mortality adjusted for displacement according to Equation (4).
(B) The blue curve is the estimated probability density function for years of life lost (YLL) obtained
from Equation (1), and the blue curve is the probability density function for YLL after adjusting for
mortality displacement.
4. Discussion and Conclusions
The debate about the necessity of non-pharmaceutical intervention, and the extent of
such measures, is still raging, and in Scandinavia one of the hottest issues in this debate
is how to measure the real mortality and the years of life lost that can be attributed to
COVID-19. The purpose of this paper is to scrutinize claims that all-cause excess mortality
deviates substantially from the official COVID-19 mortality reported in Norway and
Sweden, and that an explanation for such a claimed difference could be explained as a
mortality displacement from one season to the next.
Since COVID-19 mortality is much higher among the elderly and frail, it is also often
argued that even though the death numbers are high, the years of life lost may be rather
insignificant. For policy makers, who generally have to weigh the perils of YLL against
those of strong interventions, it should be of interest to have the YLL quantified. Thus, this
has been the second objective of this paper.
A dynamic web page published by The Economist, updated on 9 March 2021 [22],
shows a time series of the weekly number of deaths that governments have officially
attributed to COVID-19, which are compared to all-cause excess death figures in 71 coun-
tries, including Norway and Sweden. The general worldwide picture shown there is that
the waves in excess mortality coincide with those in the official COVID-19 mortality, but
typically are somewhat higher, indicating that the general under-reporting of COVID-19
deaths is more important than the over-attribution of deaths to COVID-19 due to failure of
paying notice to co-morbidity.
Until 14 October 2020, this page applied the P-score for the estimation of excess deaths,
but after this date it appears that they have applied the Z-score or a method similar to ours
(see Section 2.3). Their graphs for excess deaths and official COVID-19 deaths for the first
wave in Norway and Sweden are almost identical to Figure 1 D and E. On that page the
curves are continued into the second wave and up to 14 February 2021. In Norway, the
excess all-cause mortality drops in the late autumn and goes negative around 1 December,
while the COVID-19 death rate remains low and fairly constant. In Sweden the two death
rates grow and are almost the same up to 1 January 2021, but then the all-cause rate drops
rapidly and becomes negative on 7 February, while the COVID-19 rate peaks at 17 January,
and then starts to decline. Up to the end of 2020, the rate COVID-19 deaths per capita stays
about 10 times higher in Sweden than in Norway, and so does the all-cause mortality. The
drop in all-cause mortality in both countries after new year may be attributed to the total
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absence of the seasonal influenza so far in the season 2020/21 and perhaps to some extent,
the increasing number of elderly immunized by vaccines.
Even though our results confirm those presented by the The Economist, they differ
from those of Juul et al. (2020) [9], who suggest that all-cause mortality in Norway and
Sweden during the first wave of the COVID-19 epidemic up to July 2020 was largely
unchanged compared to the previous four years and that the high excess mortality observed
in Sweden during the epidemic wave was partly due to a mild influenza season during the
winter of 2019/20. In that paper, the 5741 COVID-19-related deaths in Sweden reported
between 11 March and 26 July were interpreted partly as a mortality displacement within
the epidemic year 2019/20 and from this year to the next, with the implication that few
years of life were lost.
It is commonly claimed, as done in [9], that all-cause mortality rates are more reliable
than reported COVID-19-related deaths. The results presented in this paper show that if
our model for estimating the expected mortality rate is used, the two rates agree within the
confidence range of the estimated all-cause excess rate. Our corresponding estimates of
YLL are consistent with Oh et al. [23].
Another central issue raised in [9] is whether the COVID-19 peak in the all-cause
mortality rate observed in Swedish data could be explained as mortality displacement,
either from the preceding year or from the months preceding the epidemic wave within
the epidemic year 2019/20, or from both. In Section 3.2 we found that the negative excess
death number (−1596) in 2018/19 constitutes less than 40% of the positive excess (+4329)
in 2019/20, so such a displacement can at best only explain part of this excess. Most
likely, there is no strong causal link between excess mortality in those two years, since
our estimate of the auto-correlation function of the excess mortality over the last 20 years
shows a very small negative correlation between successive years. This weak correlation
also indicates that mortality displacement makes an insignificant correction to our estimate
of more than 40,000 years of life lost in Sweden as an effect of the first pandemic wave.
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